标题
Prognostic Factors for Chronic Lymphocytic Leukemia
作者
关键词
Chronic lymphocytic leukemia, Treatment, Prognostication
出版物
Current Hematologic Malignancy Reports
Volume 11, Issue 1, Pages 37-42
出版商
Springer Nature
发表日期
2016-01-09
DOI
10.1007/s11899-015-0294-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Initial treatment of CLL: integrating biology and functional status
- (2015) N. Jain et al. BLOOD
- The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia
- (2015) J. R. Brown et al. BLOOD
- Three-year follow-up of treatment-naive and previously treated patients with CLL and SLL receiving single-agent ibrutinib
- (2015) J. C. Byrd et al. BLOOD
- Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens
- (2015) Philip A. Thompson et al. CANCER
- Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia
- (2015) Andrea Visentin et al. Clinical Lymphoma Myeloma & Leukemia
- Role of microRNA in chronic lymphocytic leukemia onset and progression
- (2015) Veronica Balatti et al. Journal of Hematology & Oncology
- Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia
- (2015) A M Hurtado et al. Blood Cancer Journal
- Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
- (2015) Kami J. Maddocks et al. JAMA Oncology
- PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia
- (2014) M. Weisser et al. BLOOD
- Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
- (2014) R. Claus et al. BLOOD
- Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations
- (2014) J. C. Riches et al. BLOOD
- Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
- (2014) N. Pflug et al. BLOOD
- Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR
- (2014) Sara Raponi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases
- (2014) Massimo Gentile et al. BRITISH JOURNAL OF HAEMATOLOGY
- CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia
- (2014) Pietro Bulian et al. JOURNAL OF CLINICAL ONCOLOGY
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microenvironmental Interactions in Chronic Lymphocytic Leukemia: The Master Role of CD49d
- (2014) Michele Dal Bo et al. SEMINARS IN HEMATOLOGY
- The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
- (2013) Gabriele Brachtl et al. ANNALS OF HEMATOLOGY
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
- (2012) Kirsten Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial
- (2012) Sebastian Böttcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia
- (2011) Douglas E. Gladstone et al. LEUKEMIA & LYMPHOMA
- High Serum Thymidine Kinase 1 Level Predicts Poorer Survival in Patients With Chronic Lymphocytic Leukemia
- (2010) Sergej N. Konoplev et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL
- (2010) Aneela Majid et al. LEUKEMIA RESEARCH
- The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
- (2009) D. Rossi et al. CLINICAL CANCER RESEARCH
- Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
- (2008) L. Z. Rassenti et al. BLOOD
- Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
- (2008) C. S. Tam et al. BLOOD
- CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential
- (2008) Tait D. Shanafelt et al. BRITISH JOURNAL OF HAEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started